Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Coleman

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Cardiovascular Pharmacology|May 31, 2003
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient miceShlomo Keidar, Tony Hayek, Marielle Kaplan, et al.
Circulation|May 5, 2004
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosteroneShlomo Keidar, Marielle Kaplan, Elsa Pavlotzky, et al.
Atherosclerosis|October 12, 2005
Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucoseTony Hayek, Khitam Hussein, Michael Aviram, et al.
Journal of Hypertension|August 12, 2010
FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient miceAviva Gamliel-Lazarovich, Anna Gantman, Raymond Coleman, et al.
Journal of Cardiovascular Pharmacology|December 12, 2003
Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient miceTony Hayek, Shadi Hamoud, Shlomo Keidar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2003
Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2Tony Hayek, Elsa Pavlotzky, Shadi Hamoud, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 14, 2003
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytesMirit Snir, Izhak Kehat, Amira Gepstein, et al.
Journal of Agricultural and Food Chemistry|January 5, 2008
Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteinsMichael Aviram, Nina Volkova, Raymond Coleman, et al.
Mechanisms of Ageing and Development|December 29, 2004
The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old ratsMarina Bar-Shai, Eli Carmeli, Raymond Coleman, et al.
Angewandte Chemie (International Ed. in English)|September 18, 2008
Amphiphilic/Bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in miceAdi Haber, Atif Mahammed, Bianca Fuhrman, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Pharmacology|May 31, 2003
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient miceShlomo Keidar, Tony Hayek, Marielle Kaplan, et al.
Circulation|May 5, 2004
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosteroneShlomo Keidar, Marielle Kaplan, Elsa Pavlotzky, et al.
Atherosclerosis|October 12, 2005
Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucoseTony Hayek, Khitam Hussein, Michael Aviram, et al.
Journal of Hypertension|August 12, 2010
FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient miceAviva Gamliel-Lazarovich, Anna Gantman, Raymond Coleman, et al.
Journal of Cardiovascular Pharmacology|December 12, 2003
Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient miceTony Hayek, Shadi Hamoud, Shlomo Keidar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2003
Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2Tony Hayek, Elsa Pavlotzky, Shadi Hamoud, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 14, 2003
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytesMirit Snir, Izhak Kehat, Amira Gepstein, et al.
Journal of Agricultural and Food Chemistry|January 5, 2008
Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteinsMichael Aviram, Nina Volkova, Raymond Coleman, et al.
Mechanisms of Ageing and Development|December 29, 2004
The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old ratsMarina Bar-Shai, Eli Carmeli, Raymond Coleman, et al.
Angewandte Chemie (International Ed. in English)|September 18, 2008
Amphiphilic/Bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in miceAdi Haber, Atif Mahammed, Bianca Fuhrman, et al.
Pageof 7